Neuronet

Read the latest Innovative Health Initiative (IHI) funded publication that found a significant interaction between APOE status, s*x, and CSF Aβ on CSF p-tau levels

Congratulations Tyler Saunders, Natalie Jenkins, Kaj Blennow, Craig Ritchie and Graciela Muniz Terrera!

Interactions between apolipoprotein E, s*x, and amyloid-beta on cerebrospinal fluid p-tau levels in the European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS) An interaction between s*x and cerebrospinal fluid Aβ may mediate the relationship between APOE status and CSF p-tau. These data suggest tau accumulation may be independent of Aβ in females, but not males.

The goal of the Innovative Health Initiative (IHI) funded PRISM 2 project is to build on the achievements of the original PRISM project. Specifically, it aims to validate PRISM’s findings on social dysfunction in schizophrenia and Alzheimer’s disease, and investigate whether they also apply to major depressive disorder.

https://vimeo.com/687937223

Our Innovative Health Initiative (IHI) funded IMI2_Neuronet Decision Tool provides a clickable overview of the processes and procedures for Health Technology Assessment & regulatory interactions at different stages of the development pipeline

https://kb.imi-neuronet.org/admin/decision_tool